Free Webinar (45 min)

 

What clinicians need (and want!) to know about the health economic profile of new pharmaceuticals
↓ Watch the recorded webinar below:

 

With Prof. Lieven Annemans
MSc Health, PhD Econ

lieven_webinar_2021_2.jpg

  • Prof. Dr. Lieven Annemans has participated in more than 400 health economic evaluations in over 20 countries across a wide spectrum of therapeutic areas. He has also been involved as an expert in a large number of Health Technology Assessments (HTAs) and is actively involved in HTA on a European level.
  • A unique profile: academic professor, past-president of ISPOR, advisor to policy makers, trainer and consultant.
  • Highly respected for his vast international and cross-therapeutic experience, Lieven is a much sought-after advisor and educator to health policy makers and the innovative healthcare industry.
  • Author of Health economics for non-economists (Pelckmans Pro, 2018).